The Clorox Company CLX will release earnings results for its second quarter, after the closing bell on Monday, Feb. 3, 2025.
Analysts expect the Oakland, California-based company to report quarterly earnings at $1.4 per share, down from $2.16 per share in the year-ago period. Clorox projects to report revenue of $1.63 billion for the recent quarter, compared to $1.99 billion a year earlier, according to data from Benzinga Pro.
On Jan. 28, The Clorox Company said that CFO Kevin Jacobsen will retire on April 1 after almost 30 years at the company.
Clorox shares fell 1.1% to close at $158.68 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- Barclays analyst Lauren Lieberman maintained an Underweight rating and cut the price target from $139 to $130 on Jan. 17, 2025. This analyst has an accuracy rate of 60%.
- Wells Fargo analyst Chris Carey upgraded the stock from Underweight to Equal-Weight and raised the price target from $155 to $157 on Jan. 7, 2025. This analyst has an accuracy rate of 61%.
- TD Cowen analyst Robert Moskow upgraded the stock from Sell to Hold and raised the price target from $155 to $170 on Nov. 6, 2024. This analyst has an accuracy rate of 67%.
- DA Davidson analyst Linda Bolton Weiser maintained a Neutral rating and boosted the price target from $153 to $171 on Nov. 4, 2024. This analyst has an accuracy rate of 60%.
- Citigroup analyst Wendy Nicholson maintained a Neutral rating and increased the price target from $165 to $170 on Sept. 6, 2024. This analyst has an accuracy rate of 64%.
Considering buying CLX stock? Here’s what analysts think:
Read This Next:
Overview Rating:
Speculative
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.